Corvus Pharmaceuticals Inc. (CRVS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

6,767,584 $27,138 0.34%
2. 3,275,616 $13,135 3.46%
3. 1,743,712 $6,992 +1% 0.38%
4. 875,000 $3,509 -16% 0%
5.
Millennium Management

Israel Englander

381,143 $1,528 -69% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.00 14,736 Officer, Director 1,178,515 2019-11-13 Filing
$2.90 272 Officer, Director 1,163,779 2019-11-12 Filing
$3.51 142,656 Large Shareholder, Director 6,767,584 2019-08-06 Filing
$3.51 142,656 Large Shareholder, Director 6,767,584 2019-08-06 Filing
$3.54 2,500 Officer, Director 1,163,507 2019-08-07 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.37 741,440 Large Shareholder 1,389,498 2020-07-08 Filing
$5.25 796,622 Large Shareholder 2,130,938 2020-07-07 Filing
$4.00 1,400,000 Large Shareholder 2,927,560 2019-07-25 Filing
$5.01 53,240 Large Shareholder 4,327,560 2019-07-24 Filing
$5.32 39,716 Large Shareholder 4,380,800 2019-07-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 19,959 $71 0%
2. 1,000 $3 0%
3. 900 $0 0%
4. 5,000 $0 0%
News See All